<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>PENDING</status><version>v2</version><patient-age>32</patient-age><report-id>PHHY2012IN113623</report-id><gender>female</gender><reactions><reaction>Patient could not survive</reaction><reaction>Toxic epidermal necrolysis</reaction><reaction>Developed fever</reaction><reaction>Cough</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>CARBAMAZEPINE</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>VITAMIN B COMPLEX</drug-name><manufacturer/><ingredients/></drug></drugs><patient-age>32</patient-age><outcomes><outcome>Death</outcome><outcome>Required Inpatient Hospitalization</outcome></outcomes><country>India</country><geo/></meta><original><ichicsr lang="en" xmlns="">
	<ichicsrmessageheader>
		<messagetype>ichicsr</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>4053223_286</messagenumb>
		<messagesenderidentifier>NovartisPH</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20121211134650</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>1</safetyreportversion>
		<safetyreportid>PHHY2012IN113623</safetyreportid>
		<primarysourcecountry>IN</primarysourcecountry>
		<occurcountry>IN</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>2012-12-11</transmissiondate>
		<reporttype>1</reporttype>
		<serious code="1">Yes</serious>
		<seriousnessdeath>1</seriousnessdeath>
		<seriousnesslifethreatening>2</seriousnesslifethreatening>
		<seriousnesshospitalization>1</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>2</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>2012-12-08</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>2012-12-08</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>1</fulfillexpeditecriteria>
		<companynumb>PHHY2012IN113623</companynumb>
		<medicallyconfirm>1</medicallyconfirm>
		<primarysource>
			<reportergivename>M V</reportergivename>
			<reporterfamilyname>Fegade</reporterfamilyname>
			<reporterorganization>Goa Medical College</reporterorganization>
			<reporterdepartment>Department of Pharmacology</reporterdepartment>
			<reporterstreet>Rm No. 6, Gard Hostel,
GMC Complex Bambolim,</reporterstreet>
			<reportercity>Goa</reportercity>
			<reporterpostcode>403202</reporterpostcode>
			<reportercountry>IN</reportercountry>
			<qualification code="3">Other Health Professional</qualification>
			<literaturereference>Fegade M.V, Bhounsule S.A, Pereira I.. Can vitamin B-complex aggravate the carbamazepine induced toxic epidermal necrolysis?. Journal of Clinical and Diagnostic Research. 2012;6(9):1571-1573</literaturereference>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>NOVARTIS PHARMACEUTICAL CORPORATION</senderorganization>
			<senderdepartment>Clinical Safety and Epidemiology</senderdepartment>
			<senderfamilyname>Clinical Safety and Epidemiology</senderfamilyname>
			<senderstreetaddress>Novartis Pharmaceuticals Corp. Bldg 419, One Health Plaza</senderstreetaddress>
			<sendercity>East Hanover</sendercity>
			<senderstate>NJ</senderstate>
			<senderpostcode>07936</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<sendertel>+1800378</sendertel>
			<sendertelextension>8567</sendertelextension>
			<sendertelcountrycode>US</sendertelcountrycode>
			<senderfax>+1973781</senderfax>
			<senderfaxextension>8001</senderfaxextension>
			<senderfaxcountrycode>US</senderfaxcountrycode>
			<senderemailaddress>gdss.configuration@pharma.novartis.com</senderemailaddress>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZZFDA</receiverorganization>
			<receiverdepartment>FDA</receiverdepartment>
			<receivertitle>Mr</receivertitle>
			<receivergivename>William</receivergivename>
			<receiverfamilyname>Taylor</receiverfamilyname>
			<receiverstreetaddress>5600 Fishers Lane Room 16B-45</receiverstreetaddress>
			<receivercity>Rockville</receivercity>
			<receiverstate>MD</receiverstate>
			<receiverpostcode>20857</receiverpostcode>
			<receivercountrycode>US</receivercountrycode>
			<receivertel>+1301827</receivertel>
			<receivertelextension>0964</receivertelextension>
			<receivertelcountrycode>US</receivertelcountrycode>
			<receiverfax>+1301594</receiverfax>
			<receiverfaxextension>0829</receiverfaxextension>
			<receiverfaxcountrycode>US</receiverfaxcountrycode>
			<receiveremailaddress>.</receiveremailaddress>
		</receiver>
		<patient>
			<patientinitial>--</patientinitial>
			<patientonsetage>32</patientonsetage>
			<patientonsetageunit>801</patientonsetageunit>
			<patientsex code="2">Female</patientsex>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Back pain</patientepisodename>
			</medicalhistoryepisode>
			<patientdeath>
				<patientautopsyyesno>3</patientautopsyyesno>
				<patientdeathcause>
					<patientdeathreportmeddraversion>15.1</patientdeathreportmeddraversion>
					<patientdeathreport>Death</patientdeathreport>
				</patientdeathcause>
			</patientdeath>
			<reaction>
				<primarysourcereaction>Patient could not survive</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Death unexplained</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Death</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionoutcome code="5">fatal</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Toxic epidermal necrolysis</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Toxic epidermal necrolysis</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Toxic epidermal necrolysis</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Developed fever</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Fever</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Pyrexia</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Cough</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Cough</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Cough</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>CARBAMAZEPINE</medicinalproduct>
				<obtaindrugcountry>IN</obtaindrugcountry>
				<drugauthorizationnumb>16-608</drugauthorizationnumb>
				<drugauthorizationcountry>IN</drugauthorizationcountry>
				<drugauthorizationholder>NOVARTIS SECTOR: PHARMA</drugauthorizationholder>
				<actiondrug code="5">Unknown</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>CARBAMAZEPINE</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Cough</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Cough</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Death</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Death</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pyrexia</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pyrexia</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Toxic epidermal necrolysis</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Toxic epidermal necrolysis</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>VITAMIN B COMPLEX</medicinalproduct>
				<obtaindrugcountry>IN</obtaindrugcountry>
				<drugauthorizationcountry>IN</drugauthorizationcountry>
				<actiondrug code="5">Unknown</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>VITAMIN B COMPLEX</activesubstancename>
				</activesubstance>
			</drug>
			<summary>
				<narrativeincludeclinical>Case number PHHY2012IN113623, an <Semaphore x="1938518" class="Disease or Finding" value="First-Degree Burn" score="1.00" ID="C76130">initial </Semaphore>literature report received from healthcare <Semaphore x="2425040" class="Occupation" value="Professional Occupation" score="1.00" ID="C75558">professional </Semaphore>on 08 Dec 2012. This report refers to a 32-year old female patient who suffering from chronic <Semaphore x="2773719" class="MedDRA LLT" value="Back pain" score="1.00" ID="10003988">backache</Semaphore>. The patient was prescribed <Semaphore x="300595" class="Medicine" value="Carbamazepine" score="0.49" ID="241093">carbamazepine </Semaphore>(<Semaphore x="2199623" class="Occupation" value="Manufacturer" score="1.00" ID="C25392">manufacturer </Semaphore>unknown) along with an intravenous combination of <Semaphore x="1342546" class="Medicine" value="Vitamin B Complex" score="0.49" ID="196851"><Semaphore x="1563328" class="Disease or Finding" value="Babesiosis" score="1.00" ID="C84581">vitamin B </Semaphore>complex </Semaphore>and <Semaphore x="287292" class="Medicine" value="Calcium" score="0.49" ID="240008">calcium</Semaphore>. The patient developed <Semaphore x="1932946" class="Disease or Finding" value="Fever" score="1.00" ID="C3038">fever</Semaphore>, <Semaphore x="1818376" class="Procedure" value="Cough When Drinking Liquids" score="1.00" ID="C104456">cough </Semaphore>and mucocutaneous manifestations of <Semaphore x="2638367" class="Disease or Finding" value="Toxic Epidermal Necrolysis" score="1.00" ID="C79777">toxic <Semaphore x="3283434" class="MedDRA LLT" value="Toxic epidermal necrolysis" score="1.00" ID="10044223">epidermal necrolysis </Semaphore></Semaphore>(<Semaphore x="2638367" class="Disease or Finding" value="Toxic Epidermal Necrolysis" score="1.00" ID="C79777">TEN</Semaphore>) after 15 days of the <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment</Semaphore>. The patient was admitted to the hospital (date unknown) and she was treated in the hospital with systemic steroids, intravenous <Semaphore x="3028449" class="MedDRA LLT" value="Immunoglobulins" score="1.00" ID="10021496">immunoglobulins</Semaphore>, antibiotics, intravenous fluids and <Semaphore x="2594174" class="Procedure" value="Supportive Care" score="1.00" ID="C15747">supportive care</Semaphore>. In spite of these <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatments</Semaphore>, the patient could <Semaphore x="2108196" class="AnatomicStructure" value="Lesser Trochanter" score="1.00" ID="C32982">not survive for more than </Semaphore>seven days. The <Semaphore x="2895537" class="MedDRA LLT" value="Death" score="1.00" ID="10011906"><Semaphore x="1728496" class="Disease or Finding" value="Cause of Death" score="1.00" ID="C81239">cause of death </Semaphore>was unknown</Semaphore>. It was not reported that <Semaphore x="1558453" class="Disease or Finding" value="Autopsy TNM Finding" score="1.00" ID="C48882">autopsy </Semaphore>was performed or not. The <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome </Semaphore>of event was not reported.</narrativeincludeclinical>
				<sendercomment>
Review of available reported data does not allow for a proper causality assessment. Reported event "death" is unassessable</sendercomment>
			</summary>
		</patient>
	</safetyreport>
</ichicsr></original></faers>